Earnings · China A-shares
Hinova Pharmaceuticals, Inc. Class A (688302) earnings
Hinova Pharmaceuticals, Inc. Class A published its Q3 report on 2026-10-30: net profit -1.39% year on year, +5.11% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +8.60% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -1.39%
- Excl. one-offs YoY
- +5.11%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.97% | — |
| 3 days | +8.60% | — |
| 7 days | +9.62% | — |
| 14 days | -9.59% | — |
Report history
Over the last 8 reports, net profit grew year on year in 7 of them. The stock rose in the 3 trading days after 3 of 7 reports (average -0.69%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | -¥100.53M | -1.39% | +5.11% | +267.11% | -1.02 | -9.92% | +8.60% | — | — |
| 2026 interim report | 2026-08-27 | -¥56.22M | +9.11% | +7.44% | +317.48% | -0.57 | -5.43% | -4.31% | -17.86% | -8.92% |
| 2026 Q1 report | 2026-04-25 | -¥29.88M | +6.91% | +5.14% | — | -0.30 | -2.85% | -12.74% | -26.57% | -26.27% |
| 2025 annual report | 2026-04-25 | -¥137.25M | +31.20% | +22.82% | +5480.11% | -1.39 | -12.17% | -12.74% | -26.57% | -26.27% |
| 2025 Q3 report | 2025-10-31 | -¥99.15M | +35.65% | +28.35% | +21180.28% | -1.00 | -8.65% | -10.04% | +6.38% | +11.07% |
| 2025 interim report | 2025-08-14 | -¥61.85M | +38.40% | +33.63% | +11899.08% | -0.62 | -5.31% | +11.46% | -7.63% | -16.97% |
| 2025 Q1 report | 2025-04-26 | -¥32.10M | +32.01% | +28.94% | — | -0.32 | -2.73% | +2.52% | +48.03% | +44.79% |
| 2024 annual report | 2025-04-19 | -¥199.50M | +32.18% | +33.08% | — | -2.01 | -15.59% | -0.33% | +20.01% | +17.06% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.